INOTEK PHARMACEUTICALS CORP - COM (ITEK)

CUSIP: 45780V102

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
11,886,255
Share change
+3,363,446
Total reported value
$31,021,000
Price per share
$2.61
Number of holders
31
Value change
+$9,271,280
Number of buys
18
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 45780V102?
CUSIP 45780V102 identifies ITEK - INOTEK PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOTEK PHARMACEUTICALS CORP - COM (ITEK) as of Q4 2017

As of 31 Dec 2017, INOTEK PHARMACEUTICALS CORP - COM (ITEK) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,886,255 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., Opaleye Management Inc., JENNISON ASSOCIATES LLC, Ghost Tree Capital, LLC, Boxer Capital, LLC, Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, SENZAR ASSET MANAGEMENT, LLC, Point72 Asset Management, L.P., and D. E. Shaw & Co., Inc.. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.